Pro Dex (PDEX) FCF Margin (2010 - 2026)

Pro Dex (PDEX) posted FCF Margin of 7.62% for Q1 2026, down 59.37% sequentially from 18.76% in Q4 2025, and up 433.0% YoY from 1.43% in Q1 2025.

Pro Dex (PDEX) FCF Margin (2010 - 2026) Analysis & Trends

Pro Dex has reported FCF Margin for 14 years, with the latest figure at 7.62% in Q1 2026.

Quarterly FCF Margin rose 433.0% year-over-year to 7.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.46% (up 1198.0% YoY) and the FY2025 annual result came in at 2.53%, down 1409.0% from the prior year.
FCF Margin retreated to 7.62% in Q1 2026 per PDEX's latest filing, from 18.76% in the prior quarter.
Over five years, FCF Margin peaked at 27.71% in Q1 2024 and troughed at 44.76% in Q2 2022.
A 5-year average of 3.21% and a median of 5.89% in 2023 frame the typical range for FCF Margin.
The sharpest annual moves came in 2023 and 2024: FCF Margin surged 5066 bps in 2023, then slumped 2855 bps in 2024.
Over 5 years, FCF Margin stood at 8.01% in 2022, then soared by 108 bps to 0.61% in 2023, then tumbled by 4668 bps to 27.94% in 2024, then soared by 167 bps to 18.76% in 2025, then sank by 59 bps to 7.62% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 7.62%, 18.76%, and 11.94% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	32.79%
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	12.70%
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	4.82%
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	27.57%
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	7.86%
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	9.26%
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	6.52%
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	8.91%
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	6.11%
10	Pro Dex	209.47 Mn	198.49 Mn	6.13 Mn	7.62%

Download Data